Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Alternative transplant donor sources: is there any consensus?

Fuchs E, O'Donnell PV, Brunstein CG.

Curr Opin Oncol. 2013 Mar;25(2):173-9. doi: 10.1097/CCO.0b013e32835d815f. Review.

PMID:
23385861
3.

T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.

Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK, Morris LE, Solomon SR.

J Clin Oncol. 2013 Apr 1;31(10):1310-6. doi: 10.1200/JCO.2012.44.3523. Epub 2013 Feb 19.

PMID:
23423745
4.

Algorithm for donor selection in 2011.

Arcese W, Mangione I, Picardi A.

Curr Opin Hematol. 2011 Nov;18(6):401-7. doi: 10.1097/MOH.0b013e32834ba838.

PMID:
21946072
5.

Cord blood versus haploidentical stem cell transplantation for hematological malignancies.

Kekre N, Antin JH.

Semin Hematol. 2016 Apr;53(2):98-102. doi: 10.1053/j.seminhematol.2016.01.007. Epub 2016 Jan 15. Review.

PMID:
27000733
6.

Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders.

Kwon M, Balsalobre P, Serrano D, Pérez Corral A, Buño I, Anguita J, Gayoso J, Diez-Martin JL.

Biol Blood Marrow Transplant. 2013 Jan;19(1):143-9. doi: 10.1016/j.bbmt.2012.08.019. Epub 2012 Sep 6.

7.

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H.

Cytotherapy. 2001;3(4):253-60.

PMID:
12171713
8.

[Umbilical cord blood as a source of stem cells].

Bojanić I, Golubić Cepulić B.

Acta Med Croatica. 2006 Jun;60(3):215-25. Review. Croatian.

PMID:
16933834
9.

New insights into cord blood stem cell transplantation.

Tse W, Bunting KD, Laughlin MJ.

Curr Opin Hematol. 2008 Jul;15(4):279-84. doi: 10.1097/MOH.0b013e328304ae2c. Review.

PMID:
18536563
10.

Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.

Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Schmitz M, Fischer J, Göbel U, Enczmann J, Dilloo D.

Biol Blood Marrow Transplant. 2007 Nov;13(11):1338-45. Epub 2007 Sep 21.

12.

Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?

Ruggeri A, Ciceri F, Gluckman E, Labopin M, Rocha V; Eurocord and Acute Leukemia Working Party of the European Blood and Marrow Transplant Group.

Best Pract Res Clin Haematol. 2010 Jun;23(2):207-16. doi: 10.1016/j.beha.2010.06.002. Review.

PMID:
20837332
13.

Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.

Wang Y, Chen F, Han Y, Fu ZZ, Tang XW, Miao M, Qiu HY, Jin ZM, Sun AN, Wu DP.

Biol Blood Marrow Transplant. 2009 Oct;15(10):1258-64. doi: 10.1016/j.bbmt.2009.05.020. Epub 2009 Jul 25.

14.

Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.

González-Vicent M, Molina B, Andión M, Sevilla J, Ramirez M, Pérez A, Díaz MA.

Eur J Haematol. 2011 Jul;87(1):46-53. doi: 10.1111/j.1600-0609.2011.01627.x.

PMID:
21692851
16.

Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.

Aversa F, Reisner Y, Martelli MF.

Blood Cells Mol Dis. 2004 Nov-Dec;33(3):294-302.

PMID:
15528148
17.

A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.

Huang XJ, Han W, Xu LP, Chen YH, Liu DH, Lu J, Chen H, Zhang YC, Jiang Q, Liu KY, Lu DP.

Chin Med J (Engl). 2004 Dec;117(12):1778-85.

PMID:
15603704
18.

Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.

Bornhäuser M, Theuser C, Soucek S, Hölig K, Klingebiel T, Blau W, Fauser A, Runde V, Schwinger W, Rutt C, Ehninger G.

Haematologica. 2000 Aug;85(8):839-47.

19.

Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.

Rizzieri DA, Koh LP, Long GD, Gasparetto C, Sullivan KM, Horwitz M, Chute J, Smith C, Gong JZ, Lagoo A, Niedzwiecki D, Dowell JM, Waters-Pick B, Liu C, Marshall D, Vredenburgh JJ, Gockerman J, Decastro C, Moore J, Chao NJ.

J Clin Oncol. 2007 Feb 20;25(6):690-7. Epub 2007 Jan 16.

PMID:
17228020
20.

Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.

di Grazia C, Raiola AM, Van Lint MT, Lamparelli T, Gualandi F, Berisso G, Bregante S, Dominietto A, Mordini N, Bruno B, Frassoni F, Bacigalupo A.

Haematologica. 2001 Jun;86(6):646-51.

Supplemental Content

Support Center